These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10854634)

  • 1. Effects of antidepressant treatments on polymorphonuclear elastase levels in patients with depression.
    Bekaroğlu M; Değer O; Karahan SC; Bilici M; Soylu C; Orem A
    J Affect Disord; 2000 Sep; 59(3):175-82. PubMed ID: 10854634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
    Versiani M; Amrein R; Stabl M
    Int Clin Psychopharmacol; 1997 Jul; 12(4):183-93. PubMed ID: 9347378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment study.
    Baldwin DS; Green M; Montgomery SA
    Int Clin Psychopharmacol; 2014 Nov; 29(6):339-43. PubMed ID: 24859491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies.
    Delle Chiaie R; Pancheri P; Scapicchio P
    Am J Clin Nutr; 2002 Nov; 76(5):1172S-6S. PubMed ID: 12418499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L-methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder.
    Pancheri P; Scapicchio P; Chiaie RD
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):287-94. PubMed ID: 12466028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are there differences by gender in response to pharmacotherapy for depression?
    Marsland TW; Newton W
    J Fam Pract; 2000 Dec; 49(12):1149. PubMed ID: 11132066
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy.
    Grosse L; Carvalho LA; Birkenhager TK; Hoogendijk WJ; Kushner SA; Drexhage HA; Bergink V
    Psychopharmacology (Berl); 2016 May; 233(9):1679-88. PubMed ID: 25953327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial comparing moclobemide and moclobemide plus interpersonal psychotherapy in the treatment of dysthymic disorder.
    de Mello MF; Myczcowisk LM; Menezes PR
    J Psychother Pract Res; 2001; 10(2):117-23. PubMed ID: 11264335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression.
    Thase ME; Rush AJ; Howland RH; Kornstein SG; Kocsis JH; Gelenberg AJ; Schatzberg AF; Koran LM; Keller MB; Russell JM; Hirschfeld RM; LaVange LM; Klein DN; Fawcett J; Harrison W
    Arch Gen Psychiatry; 2002 Mar; 59(3):233-9. PubMed ID: 11879161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil peripheral count and human leukocyte elastase during chronic lithium carbonate therapy.
    Capodicasa E; Russano AM; Ciurnella E; De Bellis F; Rossi R; Scuteri A; Biondi R
    Immunopharmacol Immunotoxicol; 2000 Nov; 22(4):671-83. PubMed ID: 11105780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial.
    Katona C; Bercoff E; Chiu E; Tack P; Versiani M; Woelk H
    J Affect Disord; 1999 Oct; 55(2-3):203-13. PubMed ID: 10628889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open study of sertraline in patients with major depression who failed to respond to moclobemide.
    George T; Theodoros MT; Chiu E; Krapivensky N; Hokin A; Tiller JW
    Aust N Z J Psychiatry; 1999 Dec; 33(6):889-95. PubMed ID: 10619217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine.
    Bech P; Stage KB; Larsen JK; Vestergaard P; Gram LF;
    J Affect Disord; 2012 Nov; 140(3):253-9. PubMed ID: 22381949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orthostatic side effects of clomipramine and moclobemide during treatment for depression.
    Stage KB;
    Nord J Psychiatry; 2005; 59(4):298-301. PubMed ID: 16195134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders.
    Lee MS; Lee HY; Kang SG; Yang J; Ahn H; Rhee M; Ko YH; Joe SH; Jung IK; Kim SH
    J Affect Disord; 2010 Jun; 123(1-3):216-21. PubMed ID: 19914719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do tricyclic responders have different brain laterality?
    Stewart JW; Quitkin FM; McGrath PJ; Bruder GE
    J Abnorm Psychol; 1999 Nov; 108(4):707-10. PubMed ID: 10609436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-1-acid glycoprotein in major depressive disorder. Relationships to severity, response to treatment and imipramine plasma levels.
    Nieto E; Vieta E; Alvarez L; Torra M; Colom F; Gastó C
    J Affect Disord; 2000 Aug; 59(2):159-64. PubMed ID: 10837884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10.
    Vorbach EU; Arnoldt KH; Hübner WD
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():81-5. PubMed ID: 9342765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine.
    Vanderkooy JD; Kennedy SH; Bagby RM
    Can J Psychiatry; 2002 Mar; 47(2):174-80. PubMed ID: 11926080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.